Home/Filings/4/0001127602-24-005196
4//SEC Filing

Litchfield Caroline 4

Accession 0001127602-24-005196

CIK 0000310158other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 4:03 PM ET

Size

9.6 KB

Accession

0001127602-24-005196

Insider Transaction Report

Form 4
Period: 2024-02-14
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-14$58.08/sh+38,291$2,223,94189,199.194 total
  • Sale

    Common Stock

    2024-02-14$125.50/sh38,291$4,805,52150,908.194 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-02-1438,2910 total
    Exercise: $58.08From: 2016-05-01Exp: 2025-04-30Common Stock (38,291 underlying)
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.5000 to $125.5050, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Holdings include shares acquired in dividend reinvestment transactions.
  • [F3]Exercise price and holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. ("Organon") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the "Form 10"). As reported in the Form 10, all Merck stock option awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments.
  • [F4]The option vested and became exercisable in equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001854928

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:03 PM ET
Size
9.6 KB